Amcor Earnings Call Transcripts
Fiscal Year 2027
-
Organic volumes rose 1%, with focus categories up 3%, while adjusted EPS was $0.95. Higher energy and distribution costs lowered transition-period EPS guidance; 2027 growth and synergy targets remain intact.
Fiscal Year 2026
-
Integration synergies are ahead of schedule, supporting double-digit EPS growth and robust revenue synergies. Capital allocation focuses on organic growth, deleveraging, and targeted portfolio pruning, with private label and high-growth categories prioritized for expansion.
-
Q4 and FY26 saw strong operating and financial performance, with adjusted EPS up 23% and 13% year-over-year, respectively, and synergy capture exceeding targets. Guidance for the next six months is $1.80–$1.90 EPS, with double-digit EPS growth targeted for 2027 and leverage expected to fall to ~3x.
-
Q3 results met expectations with adjusted EPS up 6% and strong synergy capture. Portfolio optimization advanced with $500 million in divestitures, and fiscal 2026 EPS is projected to grow ~12%. Free cash flow guidance was revised lower due to higher inventory, but leverage is expected to improve.
-
Q2 results met expectations with strong synergy realization and improved margins, driven by the Berry acquisition. Guidance for fiscal 2026 is reaffirmed, with double-digit EPS growth and improved free cash flow expected, supported by ongoing portfolio optimization and cost discipline.
-
Strong Q1 results with 18% EPS growth, robust synergy delivery, and margin expansion. Fiscal 2026 guidance reaffirmed, driven by integration benefits and not reliant on market recovery. Portfolio optimization and dividend increase highlight disciplined capital management.
Fiscal Year 2025
-
Berry acquisition drove strong Q4 growth in sales and EBIT, with integration progressing well and $260M in synergies targeted for FY 2026. Guidance calls for 12%-17% EPS growth and doubled free cash flow, despite flat volumes and ongoing North American beverage challenges.
-
Closed the Berry Global merger ahead of schedule, driving $650M in synergies over three years and expecting 12% EPS growth in FY26 from synergy delivery alone. Q3 saw stable sales and EPS growth, but North American demand remains weak. Leverage and cash flow targets reaffirmed.
-
Sequential volume and margin improvements continue, with guidance reaffirmed and healthcare growth expected to resume. The Berry Global acquisition is on track, with regulatory approvals progressing and $650 million in synergies targeted. Consumer trends remain cautious, with value-seeking behavior persisting.
-
Q2 delivered sequential volume and margin growth, with adjusted EBIT and EPS up 5% year-over-year. The merger with Berry Global is on track, with $650 million in synergies targeted and integration planning underway. Full-year guidance and strong cash flow outlook are reaffirmed.
-
Q1 2025 saw solid volume and earnings growth, with guidance reaffirmed for the year. Flexibles led growth, while Rigid Packaging improved margins despite volume declines. Strategic focus on sustainability, innovation, and portfolio expansion supports confidence in continued momentum.
Fiscal Year 2024
-
A transformational merger creates a global packaging leader with complementary portfolios, targeting $650 million in synergies and over $3 billion in annual cash flow. The deal is expected to deliver strong EPS accretion, enhanced innovation, and sustainability leadership, with minimal regulatory hurdles anticipated.
-
Fiscal 2024 ended with strong volume and margin growth, exceeding EPS and cash flow guidance. Fiscal 2025 outlook calls for 3%–8% EPS growth, continued cost discipline, and robust free cash flow, with healthcare destocking expected to end by year-end.